Age-Related Changes of Chondrogenic Growth Factors in Platelet-Rich Plasma

Operative Techniques in Orthopaedics

Volumn 22, Issue 2, 2012, Pages 49-55

  Dragoo, Jason L ^a   Korotkova, Tatiana ^a   Wasterlain, Amy S ^a   Pouliot, Michael A ^a   Kim, Hyeon Joo ^a   Golish, S Raymond ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Age; Concentration; Growth factor; Platelet rich plasma

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR; HUMAN GROWTH HORMONE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CARTILAGINOUS TISSUE; CHONDROGENESIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MESENCHYME CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; THROMBOCYTE RICH PLASMA; TISSUE REPAIR;

EID: 84861515143     PISSN: 10486666     EISSN: 15583848     Source Type: Journal    
DOI: 10.1053/j.oto.2011.11.004     Document Type: Article

References (70)

1. Pietrzak W.S., Eppley B.L. Platelet rich plasma: Biology and new technology. J Craniofac Surg 2005, 16:1043-1054.
2. Eppley B.L., Woodell J.E., Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg 2004, 114:1502-1508.
3. Carlson N.E., Roach R.B. Platelet-rich plasma: Clinical applications in dentistry. J Am Dent Assoc 2002, 133:1383-1386.
4. Mishra A., Woodall J., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009, 28:113-125.
5. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
6. Kazakos K., Lyras D.N., Verettas D., et al. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury 2009, 40:801-805.
7. Wrotniak M., Bielecki T., Gaździk T.S. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil 2007, 9:227-238.
8. Sun Y., Feng Y., Zhang C.Q., et al. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 2010, 34:589-597.
9. Mishra A., Tummala P., King A., et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 2009, 15:431-435.
10. Wu W., Zhang J., Dong Q., et al. Platelet-rich plasma-A promising cell carrier for micro-invasive articular cartilage repair. Med Hypotheses 2009, 72:455-457.
11. Kalen A., Wahlström O., Linder C.H., et al. The content of bone morphogenetic proteins in platelets varies greatly between different platelet donors. Biochem Biophys Res Commun 2008, 375:261-264.
12. Wahlström O., Linder C., Kalén A., et al. Acidic preparations of platelet concentrates release bone morphogenetic protein-2. Acta Orthop 2008, 79:433-437.
13. Barrientos S., Stojadinovic O., Golinko M.S., et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
14. Sipe J.B., Zhang J., Waits C., et al. Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone 2004, 35:1316-1322.
15. Martin J.A., Buckwalter J.A. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002, 3:257-264.
16. Meachim G. Age-related degeneration of patellar articular cartilage. J Anat 1982, 134:365-371.
17. Mosher T.J., Dardzinski B.J., Smith M.B. Human articular cartilage: Influence of aging and early symptomatic degeneration on the spatial variation of T2-Preliminary findings at 3 T. Radiology 2000, 214:259-266.
18. Okuda S., Myoui A., Ariga K., et al. Mechanisms of age-related decline in insulin-like growth factor-I dependent proteoglycan synthesis in rat intervertebral disc cells. Spine 2001, 26:2421-2426.
19. Chubinskaya S., Kumar B., Merrihew C., et al. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 2002, 1588:126-134.
20. Claffey K.P., Brown L.F., del Aguila L.F., et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996, 56:172-181.
21. Kim K.J., Li B., Winer J., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844.
22. Melnyk O., Shuman M.A., Kim K.J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res 1996, 56:921-924.
23. McQueeney K., Dealy C.N. Roles of insulin-like growth factor-I (IGF-1) and IGF-1 binding protein-2 (IGFBP-2) and -5 (IGFBP5) in developing chick limbs. Growth Horm IGF Res 2001, 11:346-363.
24. Neidel J., Blum W.F., Schaeffer H.J., et al. Elevated levels of insulin-like growth factor. (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-1 of articular chondrocyte proteoglycan synthesis. Rheumatol Int 1997, 17:29-37.
25. Spagnoli A., Longobardi L., O'Rear L. Cartilage disorders: Potential therapeutic use of mesenchymal stem cells. Endocr Dev 2005, 9:17-30.
26. Zimmermann R., Jakubietz R., Jakubietz M., et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001, 41:1217-1224.
27. Weibrich G., Kleis W.K., Hafner G., et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002, 30:97-102.
28. Kiepe D., Ulinski T., Powell D.R., et al. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int 2002, 62:1591-1600.
29. Schoettler N., Brahn E. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis. Curr Opin Investig Drugs 2009, 10:425-433.
30. Thomopoulos S., Zaegel M., Das R., et al. PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling. J Orthop Res 2007, 25:1358-1368.
31. Barbero A., Ploegert S., Heberer M., et al. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 2003, 48:1315-1325.
32. Jakob M., Démarteau O., Schäfer D., et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 2001, 81:368-377.
33. Barbero A., Grogan S., Schäfer D., et al. Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage 2004, 12:476-484.
34. Lohmann C.H., Schwartz Z., Niederauer G.G., et al. Pretreatment with platelet derived growth factor-BB modulates the ability of costochondral resting zone chondrocytes incorporated into PLA/PGA scaffolds to form new cartilage in vivo. Biomaterials 2000, 21:49-61.
35. Schmidt M.B., Chen E.H., Lynch S.E. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006, 14:403-412.
36. Kieswetter K., Schwartz Z., Alderete M., et al. Platelet derived growth factor stimulates chondrocyte proliferation but prevents endochondral maturation. Endocrine 1997, 6:257-264.
37. Hunziker E.B., Wagner J., Zapf J. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 1994, 93:1078-1086.
38. Indrawattana N., Chen G., Tadokoro M., et al. Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun 2004, 30:914-919.
39. Fukumoto T., Sperling J.W., Sanyal A., et al. Combined effect of insulin-like growth factor1 and transforming growth factor-β1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 2003, 11:55-64.
40. Spagnoli A., Rosenfeld R.G. The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors. Endocrinol Metab Clin North Am 1996, 25:615-631.
41. Solchaga L.A., Penick K., Porter J.D., et al. BFGF enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005, 203:398-409.
42. Nixon A.J., Fortier L.A., Williams J., et al. Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites. J Orthop Res 1999, 17:475-487.
43. Saugy M., Robinson N., Saudan C., et al. Human growth hormone doping in sport. Br J Sports Med 2006, 40(suppl 1):i35-i39.
44. Martin I., Vunjak-Novakovic G., Yang J., et al. Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res 1999, 253:681-688.
45. Chiou M., Xu Y., Longaker M.T. Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 2006, 343:644-652.
46. Sakiyama-Elbert S.E., Das R., Gelberman R.H. Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair. J Hand Surg Am 2008, 33:1548-1557.
47. Blaney Davidson E.N., van der Kraan P.M., van den Berg W.B. TGF-β1eta and Osteoarthritis. Osteoarthritis Cartilage 2007, 15:597-604.
48. Iwasaki M., Nakata K., Nakahara H., et al. Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology 1993, 132:1603-1608.
49. Joyce M.E., Roberts A.B., Sporn M.B., et al. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990, 110:2195-2207.
50. Reinholz G.G., Fitzsimmons J.S., Casper M.E., et al. Rejuvenation of periosteal chondrogenesis using local growth factor injection. Osteoarthritis Cartilage 2009, 17:723-734.
51. Schmitt B., Ringe J., Häupl T., et al. BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation 2003, 71:567-577.
52. Kim D.J., Moon S.H., Kim H., et al. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine 2003, 28:2679-2684.
53. Sellers R.S., Peluso D., Morris E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1997, 79:1452-1463.
54. Hatakeyama Y., Tuan R.S., Shum L. Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J Cell Biochem 2004, 91:1204-1217.
55. Kramer J., Hegert C., Guan K., et al. Embryonic stem cell-derived chondrogenic differentiation in vitro: Activation by BMP-2 and BMP-4. Mech Dev 2000, 92:193-205.
56. Lin L., Hou Y., Zhao L. Articular cartilage repair using dedifferentiated articular chondrocytes and bone morphogenetic protein 4 in a rabbit model of articular cartilage defects. Arthritis Rheum 2008, 58:1067-1075.
57. Kuroda R., Usas A., Kubo S., et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006, 54:433-442.
58. Schmidmaier G., Herrmann S., Green J., et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone 2006, 39:1156-1163.
59. Steinert A., Weber M., Dimmler A., et al. Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate. J Orthop Res 2003, 21:1090-1097.
60. Chubinskaya S., Hurtig M., Rueger D.C. OP-1/BMP-7 in cartilage repair. Int Orthop 2007, 31:773-781.
61. Kiepe D., Ulinski T., Powell D.R., et al. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int 2002, 62:1591-1600.
62. Fisher M.C., Meyer C., Garber G., et al. Role of IGFBP-2, IGF-1 and IGF-1I in regulating long bone growth. Bone 2005, 37:741-750.
63. Spagnoli A., Hwa V., Horton W.A., et al. Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18 relationship to differentiation stage. J Biol Chem 2001, 276:5533-5540.
64. Schoettler N., Brahn E. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis. Curr Opin Investig Drugs 2009, 10:425-433.
65. Dai J., Rabie A.B. VEGF: An essential mediator of both angiogenesis and endochondral ossification. J Dent Res 2007, 86:937-950.
66. McGough R.L., Lin C., Meitner P., et al. Angiogenic cytokines in cartilage tumors. Clin Orthop Relat Res 2002, 397:62-69.
67. Mishra A., Collado H., Fredericson M. Platelet-rich plasma compared with corticosteroid injection for chronic lateral elbow tendinosis. PM R 2009, 1:366-370.
68. Sekido Y., Morishima Y., Ohya K. Activity of platelet-derived growth factor (PDGF) in platelet concentrates and cryopreserved platelets determined by PDGF bioassay. Vox Sang 1987, 52:27-30.
69. Ito J., Kamiya Y., Kawaguchi M. Increased content of epidermal growth factor in platelet lysates in non-insulin-dependent diabetes mellitus. Life Sci 1993, 53:717-724.
70. Heng B.C., Cao T., Lee E.H. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells 2004, 22:1152-1167.